2022
DOI: 10.1021/acssuschemeng.2c02209
|View full text |Cite
|
Sign up to set email alerts
|

Assessing the Potential of New Lignin-Based pH-Responsive Nanoparticles as Drug Carriers for Cancer Treatment

Abstract: In this study, we prepared new lignin-based pH-responsive nanoparticles (LG-M­(N)-PEG NPs) and their conjugates (LG-M­(N-DOX)-PEG NPs) by using polyethylene glycol (PEG), doxorubicin (DOX), and alkaline lignin. In these NPs, the PEG chains were conjugated to lignin by an UV irradiated thiol–ene click reaction. The hydrazine and β-thiopropionate bonds in the NPs could conduct pH-triggered release of both DOX and lignin at an acidic pH in the tumor cells. Results showed that LG-M­(N-DOX)-PEG NPs had a moderate p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
16
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(19 citation statements)
references
References 42 publications
3
16
0
Order By: Relevance
“…Primarily, they incorporated pH-responsive dynamic bonds (hydrazine and βthiopropionate bonds) to enable the targeted release of both lignin and doxorubicin for a dual anticancer effect. 158 In a similar study, Zhou et al 82 loaded doxorubicin into hollow enzymatic hydrolysable lignin in a THF/water system via hydrogen bonding, adsorption, and π−π and electrostatic interactions. Furthermore, Li et al 161 used esterified organosolv lignin to synthesize hollow microspheres with attached magnetic Fe 3 O 4 nanoparticles on their surface to load organic dyes (i.e., methylene blue and rhodamine B).…”
Section: Active Substance Encapsulation and Controlledmentioning
confidence: 99%
“…Primarily, they incorporated pH-responsive dynamic bonds (hydrazine and βthiopropionate bonds) to enable the targeted release of both lignin and doxorubicin for a dual anticancer effect. 158 In a similar study, Zhou et al 82 loaded doxorubicin into hollow enzymatic hydrolysable lignin in a THF/water system via hydrogen bonding, adsorption, and π−π and electrostatic interactions. Furthermore, Li et al 161 used esterified organosolv lignin to synthesize hollow microspheres with attached magnetic Fe 3 O 4 nanoparticles on their surface to load organic dyes (i.e., methylene blue and rhodamine B).…”
Section: Active Substance Encapsulation and Controlledmentioning
confidence: 99%
“…5(a2)). [118][119][120] TEA is usually a base but can configure a linker in bioconjugate systems with xylan. Also, xylan and drugs bind through bioconjugation when a succinic anhydride linker reacts in a DCC/DMAP medium and connects xylan to curcumin and 5fluorouracil drug.…”
Section: Other Lignocellulosic Materials In Bioconjugated Systemsmentioning
confidence: 99%
“…121,125 Besides drugs, gelatin (a polysaccharide) forms a xylan biconjugate system with ethylene glycol diglycidyl ether as a bridge; this Fig. 5 Bioconjugated systems of (a) lignin, 117,118 (b) xylan, 121 and (c) tannic acid. 122 linker has cyclical ether functional groups that form ether bonds between xylan and gelatin.…”
Section: Other Lignocellulosic Materials In Bioconjugated Systemsmentioning
confidence: 99%
“…Another strategy involves the development of lignin nanoparticles (LNPs) for loading compounds such as benzazulene (BZL) or the naturally renewable drug resveratrol. This methodology holds the potential to provide drug protection and enhance their anticancer effectiveness. , Additionally, the encapsulation of the anticancer drug adriamycin (DOX) in lignin nanoparticles resulted in enhanced utilization of DOX and improved anticancer effects. , Moreover, water-soluble modifications of hydrolyzed lignin using benzene poly­(carboxylic acid) compounds (BP-Cx-1) have demonstrated multiple biological effects on neurotransmitter receptors, ligand-gated ion channels, and transporter proteins, thereby contributing to cancer treatment . Although these methods enhance drug availability and antitumor efficacy, lignin only serves as a passive carrier or active site provider, which limits its potential as a standalone antitumor biomaterial.…”
Section: Introductionmentioning
confidence: 99%